CLINICAL_TRIALS
trial_result
· 2021-06-28
Clinical Trial Update: Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. [Phase 2]
Summary
A Phase 2 study of delgocitinib cream for discoid lupus erythematosus was terminated, with efficacy and safety results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Discoid Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2021-06-28